Core Insights - The Shenzhen Innovation Drug Development Forum showcased ten innovative drug results, highlighting Shenzhen's strength in biopharmaceutical innovation and the integration of AI in drug development [3][4]. Group 1: Innovative Drug Results - AS1501, developed by Shenzhen University of Technology and a local pharmaceutical company, is the world's first TRAIL-DR5 pathway blocker for severe liver conditions, currently in clinical phase II, with no direct global competitors [3][4]. - BrAD-R13, a small molecule drug targeting Alzheimer's disease, has completed clinical phase I and is moving towards product transformation, aiming to provide effective treatment options for millions of patients [4]. - The AI-driven autonomous experimental platform by Crystal Technology has signed a collaboration order worth $59.9 billion with overseas pharmaceutical companies, marking a significant achievement in AI drug development [5]. Group 2: Collaborations and Innovations - A collaboration agreement worth $16.4 billion was established between Pruijng and Kite for the development of the first CAR-T therapy pipeline authorized for external use, indicating a new phase in China's in-situ editing therapy [5]. - Xinlitai launched a national class 1 innovative drug, Xiliting, for type 2 diabetes treatment, characterized by rapid oral absorption and high selectivity [5]. - Leiman Bio developed a low-dose cell therapy that can achieve 100% complete remission for advanced hematological tumors and systemic lupus erythematosus, significantly reducing production costs and treatment cycles [5].

中新网深圳11月16日电 (记者索有为)正在举行的第二十七届中国国际高新技术成果交易会(简称"高交 会")上，高交会院士论坛——深圳创新药发展论坛暨重大项目签约活动举办，汇聚多位海内外院士、产 业领袖及创投精英等家热议生物医药创新浪潮。 此次论坛以"AI赋能向新而行"为主题，由深圳理工大学主办。深圳理工大学党委书记朱迪俭表示，作为 一所新型研究型大学，深圳理工大学正打通从基础研究到产业转化的全链条，也让拔尖创新人才加速成 长，该校将持续以科学家精神与特区精神为引领，在学科交叉中突破创新，在产教融合中赋能产业，为 大湾区国际科技创新中心建设与人类健康事业贡献坚实力量。 深圳市发展和改革委员会党组书记、主任郭子平表示，深圳持续推动生物医药产业高质量发展，不仅成 立市级药械产业办公室、出台系列支持政策，还建设了深圳医学科学院，布局多个国家级平台，设立超 百亿元产业基金，发力AI药物研发等新赛道。 论坛上，深圳理工大学围绕科研协作、人才培养等方面与深圳层次智慧生物、宁波酶赛生物、南京汉卫 公共卫生研究院、内蒙古自治区第四医院、深圳市百盈慈善基金会等企业、医疗机构、基金会完成8个 重大项目签约，以城校共融、开放办学等举 ...